Thursday 19 November 2009

Call for Abstracts - qPCR 2010 Event

qPCR 2010 Event – The ongoing evolution of qPCR

-------------------------------------------------------------------------

BioEPS GmbH is organizing the qPCR 2010 Event taking place April 7th – 9th, 2010 in Vienna, Austria. Scientists from all around the world will come to exchange ideas, share experiences, and discuss the exciting future of the perhaps most powerful analytical technology ever developed in the life sciences area – the quantitative real-time polymerase chain reaction (qPCR). We are proud to present 40 scientific talks from invited international scientists and diagnostic companies in the qPCR field who will show their latest research findings and newest technologies. Focus of the event will be - The ongoing evolution of qPCR.

The scientific organization is managed by international well-known scientists in the field of qPCR:

Stephen Bustin Prof. of Molecular Science, School of Medicine, London, UK
Mikael Kubista Prof. of Biotechnology, TATAA Biocenter, Sweden
Christine Mannhalter Prof. for Molecular Diagnostics in Clinical Chemistry, Med. University Vienna, Austria
Jo Vandesompele Prof. at the Center of Medical Genetics, University of Ghent, Belgium
Michael W. Pfaffl Senior Scientist and Reader in Physiology, TUM, Weihenstephan, Germany

Using qPCR the amount of target nucleic acid in a complex sample can be determined with high precision, great accuracy, excellent specificity and the ultimate sensitivity of detecting a single molecule. The technique has revolutionized all molecular sciences and diagnostic applications. Conference presentations will include MIQE guidelines & QM strategies in qPCR, high performance nucleic acid extraction, single-cell applications, Epigenetics & High-Resolution-Melt analysis, circulating nucleic acids, and application involving RNAi and microRNA.
Further developments of qPCR technology will be presented include improved instrumentation, miniaturization, high throughput platforms, cost efficacy, validity, flexibility, quality assessment and reliable Cq calculations, expression data comparisons, and interpretation.
Today there is no field in the life sciences research, molecular biology and diagnostics areas that has not introduced qPCR technology for nucleic acid analysis. The combination with reverse transcription enables determination of mRNA, microRNA and widely opens the window for “Transcriptomics” – the first step of quantitative “Gene Expression Profiling” and “Functional Genomics”.
An Industrial Exhibition will take place parallel to the symposium, with 32 leading biotechnology companies presenting their latest developments, including real-time PCR cyclers, NA extraction robots, consumables, new fluorescence dyes, NA detection and amplification chemistries, as well as real-time PCR data analysis software.

For more information about the qPCR 2010 event contact Dr. Martina Reiter martina.reiter@bioeps.com

Hope to meet you in April in Vienna!

Michael Pfaffl
scientific coordinator

No comments:

Post a Comment